<DOC>
	<DOCNO>NCT01918605</DOCNO>
	<brief_summary>The purpose study evaluate usefulness dilute non-diluted DuraSeal product spacer prostate rectum prostate cancer low-dose brachytherapy .</brief_summary>
	<brief_title>Protection Rectum From High Radiation Doses Using Spacer</brief_title>
	<detailed_description>Radiation therapy prostate cancer lead inappropriate radiation dose rectum wall lead rectum adverse effect long term patient . A resorbable space prostate rectum could decrease incidence side effect . In trial , men prostate cancer intention curative treatment low-dose brachytherapy recruit . The subject randomize receive either dilute non-diluted DuraSeal product spacer prostate rectum . Diluted non-diluted DuraSeal apply rectum prostate end brachytherapy seed implantation procedure . After implantation brachytherapy seed , needle place rectum prostate perineal skin transrectal ultrasound guidance . The proper position needle confirm injection 10-15 ml sterile saline solution . After , DuraSeal component dilute 1:1 sterile saline 6-10 ml dilute product inject use DuraSeal applicator . If subject randomize receive non-diluted DuraSeal , procedure identical exception DuraSeal component dilute . The resolution spacer follow repeat plain computer tomography ( CT ) pelvis perform day operation , day operation , 4 , 8 12 week operation . In addition , magnetic resonance image pelvis perform 12 week operation . The space create prostate rectum document plain CT magnetic resonance imaging . Rectum radiation dose calculate base scan . Time DuraSeal resolution evaluate scan . Possible side effect collect subject interview follow-up visit 4 , 8 12 week operation .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplasms Site</mesh_term>
	<mesh_term>Urogenital Neoplasms</mesh_term>
	<mesh_term>Genital Neoplasms , Male</mesh_term>
	<criteria>prostate cancer patient plan lowdose brachytherapy treatment prostate cancer willing participate study</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>brachytherapy</keyword>
	<keyword>spacer</keyword>
	<keyword>side effect</keyword>
</DOC>